Literature DB >> 24523252

Hypervalent iodine-catalyzed oxidative functionalizations including stereoselective reactions.

Fateh V Singh1, Thomas Wirth.   

Abstract

Hypervalent iodine chemistry is now a well-established area of organic chemistry. Novel hypervalent iodine reagents have been introduced in many different transformations owing to their mild reaction conditions and environmentally friendly nature. Recently, these reagents have received particular attention because of their applications in catalysis. Numerous hypervalent iodine-catalyzed oxidative functionalizations such as oxidations of various alcohols and phenols, α-functionalizations of carbonyl compounds, cyclizations, and rearrangements have been developed successfully. In these catalytic reactions stoichiometric oxidants such as mCPBA or oxone play a crucial role to generate the iodine(III) or iodine(V) species in situ. In this Focus Review, recent developments of hypervalent iodine-catalyzed reactions are described including some asymmetric variants. Catalytic reactions using recyclable hypervalent iodine catalysts are also covered.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  catalytic oxidations; hypervalent iodine; oxidants; rearrangement; stereoselective reactions

Year:  2014        PMID: 24523252     DOI: 10.1002/asia.201301582

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  25 in total

1.  Benzimidazopurine nucleosides from N6-aryl adenosine derivatives by PhI(OAc)2-mediated C-N bond formation, no metal needed.

Authors:  Sakilam Satishkumar; Mahesh K Lakshman
Journal:  Chem Commun (Camb)       Date:  2017-02-14       Impact factor: 6.222

2.  Pd-catalyzed versus uncatalyzed, PhI(OAc)2-mediated cyclization reactions of N6-([1,1'-biaryl]-2-yl)adenine nucleosides.

Authors:  Sakilam Satishkumar; Suresh Poudapally; Prasanna K Vuram; Venkateshwarlu Gurram; Narender Pottabathini; Dellamol Sebastian; Lijia Yang; Padmanava Pradhan; Mahesh K Lakshman
Journal:  ChemCatChem       Date:  2017-10-24       Impact factor: 5.686

3.  I(III)-Catalyzed Oxidative Cyclization-Migration Tandem Reactions of Unactivated Anilines.

Authors:  Tianning Deng; Emily Shi; Elana Thomas; Tom G Driver
Journal:  Org Lett       Date:  2020-10-30       Impact factor: 6.005

4.  Mechanism and Origins of Chemo- and Stereoselectivities of Aryl Iodide-Catalyzed Asymmetric Difluorinations of β-Substituted Styrenes.

Authors:  Biying Zhou; Moriana K Haj; Eric N Jacobsen; K N Houk; Xiao-Song Xue
Journal:  J Am Chem Soc       Date:  2018-11-05       Impact factor: 15.419

5.  Main Group Redox Catalysis of Organopnictogens: Vertical Periodic Trends and Emerging Opportunities in Group 15.

Authors:  Jeffrey M Lipshultz; Gen Li; Alexander T Radosevich
Journal:  J Am Chem Soc       Date:  2021-01-19       Impact factor: 15.419

6.  Enantioselective diamination with novel chiral hypervalent iodine catalysts.

Authors:  Pushpak Mizar; Aragorn Laverny; Mohammad El-Sherbini; Umar Farid; Michael Brown; Florence Malmedy; Thomas Wirth
Journal:  Chemistry       Date:  2014-07-17       Impact factor: 5.236

7.  Enantioselective dioxytosylation of styrenes using lactate-based chiral hypervalent iodine(III).

Authors:  Morifumi Fujita; Koki Miura; Takashi Sugimura
Journal:  Beilstein J Org Chem       Date:  2018-03-20       Impact factor: 2.883

8.  Thioamination of Alkenes with Hypervalent Iodine Reagents.

Authors:  Pushpak Mizar; Rebecca Niebuhr; Matthew Hutchings; Umar Farooq; Thomas Wirth
Journal:  Chemistry       Date:  2016-01-07       Impact factor: 5.236

9.  Structurally Defined Molecular Hypervalent Iodine Catalysts for Intermolecular Enantioselective Reactions.

Authors:  Stefan Haubenreisser; Thorsten H Wöste; Claudio Martínez; Kazuaki Ishihara; Kilian Muñiz
Journal:  Angew Chem Int Ed Engl       Date:  2015-11-24       Impact factor: 15.336

10.  Iodoarene-catalyzed cyclizations of N-propargylamides and β-amidoketones: synthesis of 2-oxazolines.

Authors:  Somaia Kamouka; Wesley J Moran
Journal:  Beilstein J Org Chem       Date:  2017-08-31       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.